Ligand Pharmaceuticals Statistics
Total Valuation
Morgan Stanley has a market cap or net worth of $224.22 billion. The enterprise value is $140.41 billion.
Important Dates
The last earnings date was Wednesday, July 16, 2025, before market open.
| Earnings Date | Jul 16, 2025 |
| Ex-Dividend Date | Jul 31, 2025 |
Share Statistics
Morgan Stanley has 1.60 billion shares outstanding. The number of shares has decreased by -1.39% in one year.
| Current Share Class | 1.60B |
| Shares Outstanding | 1.60B |
| Shares Change (YoY) | -1.39% |
| Shares Change (QoQ) | -0.44% |
| Owned by Insiders (%) | 0.20% |
| Owned by Institutions (%) | 62.84% |
| Float | 1.22B |
Valuation Ratios
The trailing PE ratio is 15.91 and the forward PE ratio is 15.30. Morgan Stanley's PEG ratio is 1.55.
| PE Ratio | 15.91 |
| Forward PE | 15.30 |
| PS Ratio | 3.39 |
| Forward PS | 3.18 |
| PB Ratio | 2.28 |
| P/TBV Ratio | 2.97 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.55 |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 9.93 |
| EV / Sales | 2.14 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.14, with a Debt / Equity ratio of 4.39.
| Current Ratio | 2.14 |
| Quick Ratio | 1.70 |
| Debt / Equity | 4.39 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 14.13%.
| Return on Equity (ROE) | 14.13% |
| Return on Assets (ROA) | 1.16% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | n/a |
| Revenue Per Employee | $820,150 |
| Profits Per Employee | $176,763 |
| Employee Count | 80,000 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, Morgan Stanley has paid $4.40 billion in taxes.
| Income Tax | 4.40B |
| Effective Tax Rate | 22.79% |
Stock Price Statistics
The stock price has increased by +46.54% in the last 52 weeks. The beta is 1.32, so Morgan Stanley's price volatility has been higher than the market average.
| Beta (5Y) | 1.32 |
| 52-Week Price Change | +46.54% |
| 50-Day Moving Average | 136.97 |
| 200-Day Moving Average | 127.95 |
| Relative Strength Index (RSI) | 50.36 |
| Average Volume (20 Days) | 5,562,575 |
Short Selling Information
The latest short interest is 14.94 million, so 0.94% of the outstanding shares have been sold short.
| Short Interest | 14.94M |
| Short Previous Month | 14.93M |
| Short % of Shares Out | 0.94% |
| Short % of Float | 1.22% |
| Short Ratio (days to cover) | 2.51 |
Income Statement
In the last 12 months, Morgan Stanley had revenue of $65.61 billion and earned $14.14 billion in profits. Earnings per share was $8.83.
| Revenue | 65.61B |
| Gross Profit | 56.74B |
| Operating Income | 23.31B |
| Pretax Income | n/a |
| Net Income | 14.14B |
| EBITDA | n/a |
| EBIT | n/a |
| Earnings Per Share (EPS) | $8.83 |
Full Income StatementBalance Sheet
The company has $563.00 billion in cash and $479.19 billion in debt, giving a net cash position of $83.81 billion or $52.50 per share.
| Cash & Cash Equivalents | 563.00B |
| Total Debt | 479.19B |
| Net Cash | 83.81B |
| Net Cash Per Share | $52.50 |
| Equity (Book Value) | 109.27B |
| Book Value Per Share | 61.59 |
| Working Capital | 604.86B |
Full Balance SheetCash Flow
| Operating Cash Flow | -17.67B |
| Capital Expenditures | -3.27B |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Full Cash Flow StatementMargins
Gross margin is 86.48%, with operating and profit margins of 35.53% and 22.49%.
| Gross Margin | 86.48% |
| Operating Margin | 35.53% |
| Pretax Margin | 29.40% |
| Profit Margin | 22.49% |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of $4.00, which amounts to a dividend yield of 2.85%.
| Dividend Per Share | $4.00 |
| Dividend Yield | 2.85% |
| Dividend Growth (YoY) | 8.63% |
| Years of Dividend Growth | 11 |
| Payout Ratio | 42.76% |
| Buyback Yield | 1.39% |
| Shareholder Yield | 4.23% |
| Earnings Yield | 6.31% |
| FCF Yield | n/a |
Dividend DetailsAnalyst Forecast
The average price target for Morgan Stanley is $138.25, which is -1.57% lower than the current price. The consensus rating is "Buy".
| Price Target | $138.25 |
| Price Target Difference | -1.57% |
| Analyst Consensus | Buy |
| Analyst Count | 13 |
| Revenue Growth Forecast (5Y) | 3.28% |
| EPS Growth Forecast (5Y) | 6.24% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on January 27, 2000. It was a forward split with a ratio of 2:1.
| Last Split Date | Jan 27, 2000 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |
